These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 201086)
41. Epstein-Barr virus induced differentiation of early B-lineage cells. Kubagawa H; Burrows PD; Grossi CE; Cooper MD Curr Top Microbiol Immunol; 1986; 132():246-50. PubMed ID: 3024917 [No Abstract] [Full Text] [Related]
42. Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia. Katsuki T; Yamaguchi K; Matsuoka Y; Hinuma Y AIDS Res; 1986 Dec; 2 Suppl 1():S125-30. PubMed ID: 3030343 [TBL] [Abstract][Full Text] [Related]
43. A novel approach to establishing permanent lymphoblastoid cell lines: Epstein-Barr virus transformation of cryopreserved lymphocytes. Louie LG; King MC Am J Hum Genet; 1991 Mar; 48(3):637-8. PubMed ID: 1847792 [No Abstract] [Full Text] [Related]
44. Viral latency and transformation: the strategy of Epstein-Barr virus. Klein G Cell; 1989 Jul; 58(1):5-8. PubMed ID: 2546674 [No Abstract] [Full Text] [Related]
45. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus. Aguirre AJ; Robertson ES J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735 [TBL] [Abstract][Full Text] [Related]
46. Epstein-Barr virus persistence and virus-associated tumours. Niedobitek G; Young LS Lancet; 1994 Feb; 343(8893):333-5. PubMed ID: 7905149 [TBL] [Abstract][Full Text] [Related]
47. Effect of n-butyrate on transformation of human lymphocytes by Epstein-Barr virus. Roubalová K; Roubal J Intervirology; 1985; 23(1):51-4. PubMed ID: 2982760 [TBL] [Abstract][Full Text] [Related]
48. Sample age and Epstein-Barr virus transformation of cryopreserved lymphocytes. Reidy JA; Wheeler VA In Vitro Cell Dev Biol; 1992 Jun; 28A(6):383-4. PubMed ID: 1321805 [No Abstract] [Full Text] [Related]
49. The role of Epstein-Barr virus in human B cell malignancies. Bornkamm GW Haematologica; 1987; 72(6 Suppl):67-70. PubMed ID: 2832280 [No Abstract] [Full Text] [Related]
50. Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants. Wilson G; Miller G Virology; 1979 Jun; 95(2):351-8. PubMed ID: 223286 [No Abstract] [Full Text] [Related]
51. Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. Miyazaki I; Cheung RK; Dosch HM J Exp Med; 1993 Aug; 178(2):439-47. PubMed ID: 8393476 [TBL] [Abstract][Full Text] [Related]
53. Epstein-Barr virus: a ubiquitous agent that can immortalize cells. Smith RD Hum Pathol; 1993 Mar; 24(3):233-4. PubMed ID: 8384157 [No Abstract] [Full Text] [Related]
54. Cord blood mononuclear cell transformation assay for screening for the presence of Epstein-Barr virus. Lucas KG; Burton R; Heilman DK; Pollok K; Emanuel D J Hematother; 1997 Dec; 6(6):587-90. PubMed ID: 9483194 [TBL] [Abstract][Full Text] [Related]
55. Regions of the EBV genome involved in latency and lymphocyte immortalization. Miller G Prog Med Virol; 1984; 30():107-28. PubMed ID: 6087408 [No Abstract] [Full Text] [Related]
56. [Molecular mechanisms of establishment and disruption of Epstein-Barr virus latency]. Takada K Tanpakushitsu Kakusan Koso; 1989 Jun; 34(7):823-34. PubMed ID: 2552500 [No Abstract] [Full Text] [Related]
57. Use of Epstein-Barr virus to transform fetal human spleen cells for HLA typing. Mandel TE; Tait BD Transplantation; 1984 Oct; 38(4):436-7. PubMed ID: 6093295 [No Abstract] [Full Text] [Related]